Placing This Stock in the Hotbed: ABIOMED, Inc. (NASDAQ:ABMD)

ABIOMED, Inc. (NASDAQ:ABMD) has moved -2.36% over the past week and is currently priced at $233.72 after moving 0.68% in the most recent session.  Despite the cheap price tag, let’s take a closer look at the recent performance and where the price is situated in comparison to its averages.

Here we’ll take a quick glance at how the stock price is currently trading in relation to some of its simple moving averages. At current levels, ABIOMED, Inc. (NASDAQ:ABMD) shares have been seen trading 0.41% away from the 20-day moving average. The stock has been recently separated from the 50-day moving average by 11.47%. Using a broader approach, shares have been trading 37.85% off of the 200-day moving average. After the latest check-in, company stock is -8.50% off of the 50 day high and 25.17% away from the 50 day low price.

Analysts are predicting earnings per share growth of 37.30% for the current year. The earnings per share growth over the next five years are expected to be 38.00%. ABIOMED, Inc. has had earnings per share growth of 99.20% over the past five years. 

Earnings per share (EPS) the amount of income that “belongs” to each share of common stock. This is a valuable tool that investors use to determine the value and projected value of a stock.  Earnings per share is generally reported in annualized form from the most recent fiscal year. To determine the value, the average number of shares outstanding is usually calculated by averaging the number of shares at the beginning of the fiscal period and the number of shares at the end of the period. 

Currently the return on equity is 16.00% and its debt to equity is 0.00. ABIOMED, Inc. has a total market cap of $10339.77, a gross margin of 83.90% while the profit margin is 16.60% and the ROI is 10.90%.

In terms of performance, we can pore into the stats for ABIOMED, Inc. (NASDAQ:ABMD).  The stock is 24.71% since the start of 2017. Over the past week, shares are -2.36%. Moving out to look at the previous month performance, the stock is at 11.22%. For the quarter, performance is at 19.53%. During the past six months, ABIOMED, Inc. (NASDAQ:ABMD)’s stock has been 54.40% and 115.13% for the last 12 months.